PMA device
SURGICEL Endoscopic Applicator
ETHICON, Inc. · Agent, Absorbable Hemostatic, Non-Collagen Based (LMG, Class III) · First FDA decision Nov 26, 2008, newest Nov 21, 2018Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
29
Naming "SURGICEL"
MAUDE reports
1,526
Brand "SURGICEL", since 2015
PubMed studies
551
Mentioning "SURGICEL"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SURGICEL Endoscopic Applicator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- SURGICEL Endoscopic ApplicatorPMA supplement
N12159-S047 · Decided Nov 21, 2018 · 180 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, non-collagen based (LMG) · General & Plastic Surgery
- SURGICEL ABSORBABLE HEMOSTAT (SURGICEL, SURGICEL NU-KNIT AND SURGICEL FIBRILLAR ABSORBABLE HEMOSTATS)PMA supplement
N12159-S023 · Decided Nov 26, 2008 · 236 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, non-collagen based (LMG) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SURGICEL", any status and sponsor, newest update first.
- Tract Closure in PCNLPivotal-lookingRecruiting
Icahn School of Medicine at Mount SinaiAcademic, hospital or other
NCT07668817 · 114 participants (planned) · Start Nov 2026 · Primary completion May 2028
Device: Floseal; Surgicel · For: Nephrolithiasis
Sites: New York, New York
- A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open SurgeryPivotal-lookingCompleted
Ethicon, Inc.Public (JNJ)
NCT06664788 · 108 participants · Start Apr 16, 2025 · Primary completion Sep 3, 2026
Device: ETHIZIA; SURGICEL Original · For: Hemostasis; Hemostatic Techniques
Sites: Los Angeles, California; St Louis, Missouri; Pennington, New Jersey · 7 sites in all
- A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Pivotal-lookingCompleted
Medprin Regenerative Medical Technologies Co., Ltd.Not on our public-company list
NCT07764055 · 288 participants · Start Nov 9, 2022 · Primary completion Jan 15, 2024
Device: Absorbable Multilayer Fibrillar Regenerated Oxidized Cellulose; SURGICEL Absorbable Hemostat (Absorbable Hemostatic Gauze) · For: Surgical Bleeding; Hemorrhage; Oxidized Regenerated Cellulose
Sites: Guangzhou, China; Hangzhou, China; Shanghai, China · 6 sites in all
26 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SURGICEL", and for the whole product code for context.
This brand
1,526 reports: 345 malfunction, 1,158 injury, 22 death
Whole product code LMG
1,626 reports: 410 malfunction, 1,192 injury, 23 death
Newest reports for this brand
- SURGICEL FIBRILLARMalfunction
2210968-2026-10795 · Received Oct 23, 2026
Device type: Agent, Absorbable Hemostatic, Non-Collagen Based (LMG)
Device problem as coded: Device Contaminated During Manufacture or Shipping
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Surgicel PowderInjury
2210968-2026-10753 · Received Oct 22, 2026
Device type: Agent, Absorbable Hemostatic, Non-Collagen Based (LMG)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hypersensitivity/Allergic reaction; Rash
- Surgicel PowderInjury
2210968-2026-10751 · Received Oct 22, 2026 · Event dated Jan 1, 2026
Device type: Agent, Absorbable Hemostatic, Non-Collagen Based (LMG)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Sepsis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SURGICEL"[tiab]. The summary above synthesizes these.
- Absorbable Hemostatic Aggregates.
Wang AY, Rafalko J, MacDonald M, et al. · ACS Biomater Sci Eng · 2017
- Surgicel-Induced Anaphylaxis Post Permacath Placement.
Corti MC, Thomas AD, Sayegh MN, et al. · Cureus · 2021Case Reports
- Using Surgicel-wrapped Merocel to reduce pain during the removal of nasal packing.
Lo WL, Yeh CF · Acta Otolaryngol · 2023
- Epistaxis Treatment Options: Literature Review.
Mylonas S, Skoulakis C, Nikolaidis V, et al. · Indian J Otolaryngol Head Neck Surg · 2023
- [Nasopalatine duct cyst].
Matijevik S, Gazivoda D, Marjanovik M, et al. · Vojnosanit Pregl · 2007Case Reports, English Abstract
- Surgicel: its fate following implantation.
Pierce AM, Wiebkin OW, Wilson DF · J Oral Pathol · 1984
- Oxidized cellulose hemostat (Surgicel).
Sugar O · Surg Neurol · 1984Editorial
- Surgicel® Granuloma Mimicking Recurrent Thyroid Tumor After Thyroidectomy: A Case Report and Literature Review.
Alameer E · Cureus · 2023Case Reports
- Surgicel mimicking early onset prosthetic valve endocarditis: case report.
Regragui H, El Boussaadani B, Oukerraj L, et al. · Eur Heart J Case Rep · 2020
- [Development of Medical Materials and Infection].
Kohara K, Kawamata T · No Shinkei Geka · 2022
- Diced Cartilage Techniques in Rhinoplasty.
Dong W, Han R, Fan F · Aesthetic Plast Surg · 2022Systematic Review
- Surgicel plug technique versus endoclose technique for port-site closure post minimally invasive (robotic and laparoscopic) surgeries: Retrospective cohort study.
Moazin MS, Alsuwailim AM, Botaiban MM, et al. · Saudi Med J · 2023
Other devices of this type
Also filed under product code LMG.
- Arista AH Absorbable Hemostatic ParticlesDavol, Inc. · PMA 2021
- PerClot® Polysaccharide Hemostatic SystemBaxter Healthcare Corporation · PMA 2026
- Surgicel / Surgicel Nu-Knit / Surgicel Fibrillar Absorbable HemostatETHICON, Inc. · PMA 2005
- SURGICELTM POWDER Absorbable Hemostatic PowderETHICON, Inc. · PMA 2026
- Surgicel Powder Absorbable Hemostatic PowderETHICON, Inc. · PMA 2017
- Arista Ah, Arista Ah Flexitip/ Flexitip Xl/ Flexitip Xl-RDavol, Inc. · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.